British Biotech drug fails trial
The first of British Biotech's advanced trials for an anti-cancer agent, once seen as a potential breakthrough in treatment of the disease, has failed. The company said that a Phase III study of
The first of British Biotech's advanced trials for an anti-cancer agent, once seen as a potential breakthrough in treatment of the disease, has failed. The company said that a Phase III study of